Researchers are exploring the use of novel nanomaterials for targeted therapy of myocardial ischemia-reperfusion injury, with studies investigating various mechanisms and approaches. The potential therapeutic strategies include nanoparticle-based drug delivery systems, composite targeted polyphenol nanoparticles, and magnetic nanocubes. These advancements aim to address the complex molecular mechanisms underlying the injury, with the goal of developing effective treatments.